The Economic Cost of Methamphetamine Use in the United States, 2005
This first national estimate suggests that the economic cost of methamphetamine (meth) use in the United States reached $23.4 billion in 2005. Given the uncertainty in estimating the costs of meth use, this book provides a lower-bound estimate of $16.2 billion and an upper-bound estimate of $48.3 billion. The analysis considers a wide range of consequences due to meth use, including the burden of addiction, premature death, drug treatment, and aspects of lost productivity, crime and criminal justice, health care, production and environmental hazards, and child endangerment. Other potential harms of meth, however, could not be included due to a lack of scientific evidence or to data issues. Although meth causes some unique harms, many of the primary cost drivers are similar to those identified in economic assessments of other illicit drugs. Among the most costly elements are the intangible burden of addiction and premature death, which account for nearly two-thirds of the economic costs. The intangible burden of addiction measures the lower quality of life experienced by those addicted to the drug. Crime and criminal-justice costs also account for a significant share of economic costs, as do lost productivity, removing a child from the parents' home, and drug treatment. One unusual cost captured in the analysis is that associated with the production of meth, which requires toxic chemicals that can result in fire, explosions, and other negative events.
- Copyright: RAND Corporation
- Availability: Web-Only
- Pages: 169
- Document Number: MG-829-MPF/NIDA
- Year: 2009
- Series: Monographs
The Cost of Methamphetamine Treatment
The Cost of Methamphetamine-Related Health Care Among Methamphetamine Users
Premature Death and the Intangible Health Burden of Addiction
Productivity Losses Due to Methamphetamine Use
The Cost of Methamphetamine-Related Crime
The Methamphetamine-Related Cost of Child Maltreatment and Foster Care
The Societal Cost of Methamphetamine Production
Consideration of Costs Not Included
Supporting Information for Estimating the Cost of Methamphetamine-Related Health Care: Inpatient Days
Additional Calculations to Support Productivity-Loss Estimates
Additional Information to Support the Cost of Methamphetamine-Related Crime
Deriving Methamphetamine Attribution Factors from the Inmate Surveys
This study was sponsored by the Meth Project Foundation and the National Institute on Drug Abuse and was conducted under the auspices of the RAND Drug Policy Research Center, a joint endeavor of RAND Infrastructure, Safety, and Environment and RAND Health.
This report is part of the RAND Corporation monograph series. RAND monographs present major research findings that address the challenges facing the public and private sectors. All RAND monographs undergo rigorous peer review to ensure high standards for research quality and objectivity.
Permission is given to duplicate this electronic document for personal use only, as long as it is unaltered and complete. Copies may not be duplicated for commercial purposes. Unauthorized posting of RAND PDFs to a non-RAND Web site is prohibited. RAND PDFs are protected under copyright law. For information on reprint and linking permissions, please visit the RAND Permissions page.
The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.